Education
About Us
Working with TipRanks
Follow Us
BioVaxys Technology (TSE:BIOV)
:BIOV
BIOV Stock Chart & Stats
C$0.17
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.17
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.20 - C$0.80
Previous CloseN/A
Volume0.00
Average Volume (3M)20.26K
Market Cap
$7.29M
Enterprise ValueC$5.96M
Total Cash (Recent Filing)$4.31K
Total Debt (Recent Filing)$133.72K
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding29,152,520
10 Day Avg. Volume17,758
30 Day Avg. Volume20,262
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-7.14
Price to Sales (P/S)0.00
P/FCF Ratio-4.69
Enterprise Value/Market Cap0.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVaxys Technology News
BIOV FAQ
What was BioVaxys Technology’s price range in the past 12 months?
BioVaxys Technology lowest stock price was C$0.20 and its highest was C$0.80 in the past 12 months.
What is BioVaxys Technology’s market cap?
BioVaxys Technology’s market cap is $7.29M.
When is BioVaxys Technology’s upcoming earnings report date?
BioVaxys Technology’s upcoming earnings report date is Mar 26, 2026 which is in 156 days.
How were BioVaxys Technology’s earnings last quarter?
BioVaxys Technology released its earnings results on Oct 02, 2025. The company reported -C$0.031 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.031.
Is BioVaxys Technology overvalued?
According to Wall Street analysts BioVaxys Technology’s price is currently Overvalued.
Does BioVaxys Technology pay dividends?
BioVaxys Technology does not currently pay dividends.
What is BioVaxys Technology’s EPS estimate?
BioVaxys Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioVaxys Technology have?
BioVaxys Technology has 29,152,520 shares outstanding.
What happened to BioVaxys Technology’s price movement after its last earnings report?
BioVaxys Technology reported an EPS of -C$0.031 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 10.909%.
Which hedge fund is a major shareholder of BioVaxys Technology?
Currently, no hedge funds are holding shares in TSE:BIOV
Company Description
BioVaxys Technology
BioVaxys Technology Corp. is a biotechnology company focused on developing viral and oncology vaccines as well as immuno-diagnostics. Operating in the life sciences sector, BioVaxys leverages its proprietary haptenization technology platform to create vaccines designed to elicit a robust immune response. The company is engaged in the development of vaccines for SARS-CoV-2, as well as therapeutic vaccines for ovarian cancer and other solid tumors.
Technical Analysis
Options Prices
Currently, No data available
---